Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/34341
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAnkeny, R.en
dc.date.issued2004en
dc.identifier.citationCambridge Quarterly of Healthcare Ethics, 2004; 13(3):241-244en
dc.identifier.issn0963-1801en
dc.identifier.issn1469-2147en
dc.identifier.urihttp://hdl.handle.net/2440/34341-
dc.description.abstractThe past year in bioethics in Australia has been relatively predictable. We continue to struggle with rising healthcare costs, though thankfully not on par with numerous other countries due to a relatively positive economic outlook. We are still fighting difficulties associated with higher medical indemnity costs, which have again caused many physicians to leave private practice, particularly in high-risk and specialty practice areas. In response, the federal government (following a shuffle of ministerial positions including that of the federal health minister) delayed the imposition of the medical indemnity levy for physicians until mid 2005. In May, the Australian Law Reform Commission and the Australian Health Ethics Commission issued their final joint report on genetic testing entitled “Essentially Yours” and endorsed use of genetic tests by insurance companies, despite the concerns of some geneticists and many members of the public about their scientific reliability. However, they also advocated the establishment of the Human Genetics Commission of Australia (HGCA) to oversee such uses of genetic tests in terms of both scientific and actuarial reliability, and debates continue over the implementation of this and a number of their other recommendations. And state governments continue to phase in smoking bans in public places, with most implementing full bans in enclosed restaurants and cafes and planning to require provision of nonsmoking areas in all pubs within the next year.en
dc.description.statementofresponsibilityRachel A. Ankenyen
dc.language.isoenen
dc.publisherCambridge Univ Pressen
dc.rightsCopyright © 2004 Cambridge University Pressen
dc.subjectHumans; Negotiating; Internationality; Politics; Drug Industry; Bioethical Issues; Cost Control; Drug Costs; Insurance, Pharmaceutical Services; United States; Australiaen
dc.titleDealing drugs with the Bushen
dc.typeJournal articleen
dc.identifier.rmid0020064590en
dc.identifier.doi10.1017/S0963180104133069en
dc.identifier.pubid50205-
pubs.library.collectionHistory publicationsen
pubs.verification-statusVerifieden
pubs.publication-statusPublisheden
dc.identifier.orcidAnkeny, R. [0000-0002-1547-6031]en
Appears in Collections:History publications

Files in This Item:
File Description SizeFormat 
hdl_34341.pdfPublished version48.16 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.